PIPELINE
Rejuvenating Brain immunity: Conquering Brain diseases
Therapeutics | Indication | Development Stage | |||||
---|---|---|---|---|---|---|---|
Hit | Lead | Candidate | IND | Clinical trial | |||
BX1001 | Aging brain |
|
|||||
ALS |
|
||||||
AD |
|
Cell technology | Indication | Target | Engineered | Validate | IND | Clinical trial | |
---|---|---|---|---|---|---|---|
BX-MG01 | GBM |
|
|||||
BX-MG02 | non-disclosure |
|
|||||
BX-MG03 | non-disclosure |
|
Culture | Indication | Discovery | Evaluation | Production | Prototype | Commercial | |
---|---|---|---|---|---|---|---|
MGmax | Source |
|
|||||
Media MGmax | Cell-free culture |
|
|||||
Protein MGmax |
|
||||||
ECM MGmax |
|